When a steroid injection is considered for outer hip pain

Persistent pain on the outside of the hip—especially when walking, climbing stairs, standing on one leg, or lying on that side—sometimes continues even after simple pain relief, activity changes and the first set of exercises from a GP or physiotherapist. In that situation, a peri‑trochanteric (outer‑hip) steroid injection is often discussed as the next step to bring symptoms down enough to keep moving and to sleep more comfortably. [trafilatura:https%3A%2F%2Fwww.nhsinform.scot%2Fillnesses-and-conditions%2Fmuscle-bone-and-joints%2Fleg-and-foot-problems-and-conditions%2Fgreater-trochanteric-pain-syndrome%2F]

This pattern commonly fits greater trochanteric pain syndrome (GTPS): pain and tenderness over the “bony bump” on the side of the hip (the greater trochanter), usually arising from irritation/overload of the gluteal tendons and nearby bursae rather than from the ball‑and‑socket hip joint itself. Community MSK guidance also notes that pain more centred in the groin is more suggestive of a hip‑joint (intra‑articular) source than typical GTPS. [trafilatura:https%3A%2F%2Fleedscommunityhealthcare.nhs.uk%2Four-services-a-z%2Fmusculoskeletal-msk%2Fhip-problems%2Fknown-diagnosed-hip-problems%2Fgreater-trochanteric-pain-syndrome-gtps-and-lateral-hip-pain%2F]

In a hip-only pathway such as Lincolnshire Hip, steroid injections for suspected GTPS are therefore aimed at the peri‑trochanteric tissues—most often the trochanteric bursa region and adjacent tendon insertions—rather than routinely placed into the hip joint. That “target choice” matters because imaging work in ultrasound-guided GTPS treatment has suggested injections into the greater trochanteric bursa may be more effective than injections directed at the subgluteus medius bursa. [google_serp:organic:https%3A%2F%2Fajronline.org%2Fdoi%2F10.2214%2FAJR.12.9443]

UK guidance places a corticosteroid injection as a second‑line option: it is usually considered when education, load modification, simple analgesia and a structured hip‑strengthening programme have not provided enough relief. Evidence syntheses also suggest steroid injections tend to help pain and function most in the short term, with exercise programmes performing better as the core long‑term strategy—so injections are best seen as an adjunct, not a replacement for rehabilitation. [google_serp:organic:https%3A%2F%2Fcks.nice.org.uk%2Ftopics%2Fgreater-trochanteric-pain-syndrome%2Fmanagement%2Fmanagement%2F; ai4scholar:a3791de42e72f7a052fe7d88cfe60fdf6647c9fb; ai4scholar:d094c277fd19ad2135c44c3a16c74bb469879c26]

A practical way to frame the decision (clinical fit matters more than logistics) is whether most of the following are true:

• Pain is mainly on the outside of the hip, tender over the greater trochanter, and worse with stairs or lying on that side. [trafilatura:https%3A%2F%2Fleedscommunityhealthcare.nhs.uk%2Four-services-a-z%2Fmusculoskeletal-msk%2Fhip-problems%2Fknown-diagnosed-hip-problems%2Fgreater-trochanteric-pain-syndrome-gtps-and-lateral-hip-pain%2F]
• A strengthening and load‑management plan has been tried but pain is still blocking walking, sleep, or progress with rehab. [google_serp:organic:https%3A%2F%2Fcks.nice.org.uk%2Ftopics%2Fgreater-trochanteric-pain-syndrome%2Fmanagement%2Fmanagement%2F]
• The goal is a temporary “window” of symptom control to enable better rehabilitation, rather than a stand‑alone cure. [ai4scholar:d094c277fd19ad2135c44c3a16c74bb469879c26]

Is your hip pain coming from the trochanteric region or the hip joint

Pain location often sets the direction of the next test or injection: in greater trochanteric pain syndrome (GTPS), the sore spot is typically the bony prominence on the outside of the hip (the greater trochanter), where the gluteal tendons (mainly gluteus medius/minimus) attach and where small bursae act as cushioning pads. NHS and UK community MSK resources describe this as a soft-tissue (tendon–bursa) problem over the lateral hip rather than a problem coming from inside the hip joint (the ball-and-socket). [trafilatura:https%3A%2F%2Fwww.nhsinform.scot%2Fillnesses-and-conditions%2Fmuscle-bone-and-joints%2Fleg-and-foot-problems-and-conditions%2Fgreater-trochanteric-pain-syndrome%2F; trafilatura:https%3A%2F%2Fleedscommunityhealthcare.nhs.uk%2Four-services-a-z%2Fmusculoskeletal-msk%2Fhip-problems%2Fknown-diagnosed-hip-problems%2Fgreater-trochanteric-pain-syndrome-gtps-and-lateral-hip-pain%2F]

A practical contrast used in UK MSK pathways is “outer hip tenderness” versus “deep groin pain”. Leeds Community Healthcare notes that pain centred in the groin is more suggestive of intra-articular hip joint pathology than typical GTPS, even though some people can feel pain more broadly around the hip and thigh. In clinic, GTPS is often easiest to recognise when the pain is very local to the outer hip and is reproduced by direct pressure over the greater trochanter, whereas hip-joint driven pain more often feels deeper and is less precisely pinpointed with a fingertip. [trafilatura:https%3A%2F%2Fleedscommunityhealthcare.nhs.uk%2Four-services-a-z%2Fmusculoskeletal-msk%2Fhip-problems%2Fknown-diagnosed-hip-problems%2Fgreater-trochanteric-pain-syndrome-gtps-and-lateral-hip-pain%2F]

Risk factors can also hint at the dominant driver. The Leeds community MSK guidance highlights GTPS as particularly common in middle-aged women and links it with reduced hip abductor strength, deconditioning, and changes in activity levels (for example, a sudden increase in walking or hill/stair exposure). That pattern fits a load-sensitive tendon–bursa overload picture more than a purely “wear-and-tear in the joint” story. [trafilatura:https%3A%2F%2Fleedscommunityhealthcare.nhs.uk%2Four-services-a-z%2Fmusculoskeletal-msk%2Fhip-problems%2Fknown-diagnosed-hip-problems%2Fgreater-trochanteric-pain-syndrome-gtps-and-lateral-hip-pain%2F]

Overlap is common, and it can blur the target. A 2022 editorial on GTPS with concomitant intra-articular disease describes the logic of using separate ultrasound-guided diagnostic injections—one into the peritrochanteric region and one into the hip joint—to help localise the main pain generator; partial relief from both can suggest mixed pathology rather than a single source. In a small 2014 series of 16 patients with stubborn lateral hip pain who had already failed peritrochanteric injections, an ultrasound-guided intra-articular hip injection alongside physiotherapy and NSAIDs was associated with improved modified Harris Hip Scores at 1 and 12 weeks, supporting the idea that “occult” hip-joint lesions can sometimes sit behind persistent lateral symptoms. [ai4scholar:1155dbee943450860dda42b176c012cca5af5327; trafilatura:https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC4765286%2F]

In a hip-only service such as Lincolnshire Hip, this distinction mainly answers one question: should an injection be aimed at the painful outer-hip tissues (typical GTPS) or placed into the hip joint because the joint is the more likely pain source—or because both appear to be contributing. Lincolnshire Hip is part of the MSK Doctors group and accepts patients without referral for hip assessment.

What an ultrasound-guided trochanteric bursa injection involves at Lincolnshire Hip

An ultrasound-guided trochanteric bursa steroid injection at Lincolnshire Hip is usually an outpatient clinic procedure, designed around accuracy and immediate aftercare rather than an operating-theatre pathway. The visit is typically easiest to think of in three parts: confirming the target on ultrasound, placing the injection under real-time imaging, and a short period of post-injection checks before walking out of clinic.

Why ultrasound guidance is used

Real-time ultrasound is used to identify the greater trochanter and the peri-trochanteric soft tissues (including the trochanteric bursa region and nearby gluteal tendons), then guide the needle to the intended depth—aiming to treat the lateral hip pain source rather than placing medication into the hip joint. In an AJR ultrasound-guided series, injections directed into the greater trochanteric bursa appeared more effective than injections into the subgluteus medius bursa, which supports the greater trochanteric bursa region as a common target in GTPS treatment pathways. [google_serp:organic:https%3A%2F%2Fajronline.org%2Fdoi%2F10.2214%2FAJR.12.9443]

One practical reason this matters is needle depth. In a 2018 randomised trial (40 patients), ultrasound assessment suggested a 2-inch (50.8 mm) needle was typically needed to reliably reach the trochanteric bursa; a key limitation of landmark-only approaches is simply not getting the steroid to the correct tissue plane. In that same study, outcomes were broadly similar early on, with only a modest difference at 6 months, so ultrasound guidance is best framed as improving confidence in placement rather than guaranteeing better long-term results for every patient. [trafilatura:https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs00296-018-3938-z]

What happens during the appointment

The procedural steps are usually straightforward:

• A brief pre-procedure discussion and consent, including confirming the painful spot on the outer hip.
• Positioning on an examination couch so the lateral hip is accessible.
• Skin cleaning, then ultrasound gel on the side of the hip.
• Local anaesthetic into the skin (often felt as a brief sharp scratch).
• Needle placement under ultrasound guidance into the trochanteric bursa region, with slow injection of corticosteroid combined with local anaesthetic.
• Needle removal and a simple dressing.

What it often feels like afterwards, and key safety points

A feeling of pressure during the injection is common, and the local anaesthetic component may leave the outer hip feeling temporarily “heavy” or numb for a short period. Most people can mobilise immediately and leave the clinic the same day.

Across hip and peri-trochanteric injections, a common short-term after-effect is a local inflammatory reaction with soreness for 24–48 hours. A key reason to defer an injection is suspected skin or soft-tissue infection at the injection site. [trafilatura:https%3A%2F%2Fwww.aafp.org%2Fafp%2F2024%2F0100%2Fhip-and-knee-injections]

Evidence comparing techniques remains mixed: a 2024 prospective study found both ultrasound-guided and landmark-guided injections improved pain (VAS) and function (modified Harris Hip Score) at 1 month and 1 year, with greater early improvement at 1 month in the ultrasound-guided group but no clear long-term superiority by 1 year. That pattern aligns with using ultrasound to optimise accuracy and early symptom control—often to help rehabilitation progress—without overselling it as a universally superior outcome. [trafilatura:https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11583939%2F]

How much benefit to expect and how long it usually lasts

Benefit from a trochanteric bursa steroid injection is usually best thought of as a time-limited “rehab window” rather than a permanent fix for outer-hip pain. The local anaesthetic can change pain quickly on the day, but the steroid effect is commonly discussed as taking a few days to settle in, with NICE CKS and UK primary-care guidance framing relief as often short term and repeat injections as something to use judiciously alongside ongoing exercise and load management. [google_serp:organic:https%3A%2F%2Fcks.nice.org.uk%2Ftopics%2Fgreater-trochanteric-pain-syndrome%2Fmanagement%2Fmanagement%2F; google_serp:organic:https%3A%2F%2Fbest.barnsleyccg.nhs.uk%2Fmedia%2Fotijtdvd%2Fgreater_trochanteric_pain_syndrome_trochanteric_bursitis-jan-2025.pdf]

When outcomes are pooled across trials, the pattern is broadly consistent with that practical framing: a 2021 systematic review of 10 randomised trials reported improvements in pain and function after corticosteroid injection for greater trochanteric pain syndrome (GTPS) in the short term, but benefits tended to diminish over longer follow-up and were often not superior to other approaches such as structured exercise (and, in some studies, biologic injections). [ai4scholar:a3791de42e72f7a052fe7d88cfe60fdf6647c9fb]

Longer-term comparisons tilt even more clearly towards rehabilitation as the “main treatment”. A 2025 network meta-analysis of 19 RCTs (1,701 participants) concluded that structured exercise programmes produced the greatest overall improvements in pain and function over time, while injection therapies (including steroid) could still produce meaningful gains in functional scores such as the Harris Hip Score, but generally did not outperform exercise as a stand-alone strategy. [ai4scholar:d094c277fd19ad2135c44c3a16c74bb469879c26]

In a hip-only pathway like Lincolnshire Hip, that evidence translates into a simple priority: steroid injection is used mainly to reduce pain enough to help rehabilitation progress (for example, hip abductor strengthening, gait retraining, and load management), rather than as a long-term solution on its own. This matches the tone of NICE CKS and UK primary-care guidance, which positions the injection as an adjunct when first-line measures have not given enough control of symptoms. [google_serp:organic:https%3A%2F%2Fcks.nice.org.uk%2Ftopics%2Fgreater-trochanteric-pain-syndrome%2Fmanagement%2Fmanagement%2F; google_serp:organic:https%3A%2F%2Fbest.barnsleyccg.nhs.uk%2Fmedia%2Fotijtdvd%2Fgreater_trochanteric_pain_syndrome_trochanteric_bursitis-jan-2025.pdf; ai4scholar:a3791de42e72f7a052fe7d88cfe60fdf6647c9fb; ai4scholar:d094c277fd19ad2135c44c3a16c74bb469879c26]

Ultrasound versus landmark guidance (and why availability differs)

Research comparing ultrasound-guided with landmark-guided trochanteric injections is mixed and based on modest-sized studies. In a 2018 randomised trial of 40 patients, pain scores were similar at 2 weeks, with only a modest advantage for ultrasound at 6 months; annual per-patient costs were about 43% higher with ultrasound, and there were no complications in either group. [trafilatura:https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs00296-018-3938-z]

A 2024 prospective comparison also found both approaches improved pain (VAS) and function (modified Harris Hip Score) at 1 month and 1 year, with greater early improvement at 1 month in the ultrasound-guided group—particularly in people starting with higher pain and disability—without clear long-term superiority by 1 year. [trafilatura:https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11583939%2F]

This “small long-term difference, debated cost-effectiveness” picture is reflected in NHS commissioning decisions: the Thames Valley Priorities Committee policy states ultrasound guidance is not normally funded for GTPS injections, with consideration mainly for refractory cases or diagnostic uncertainty. [google_serp:organic:https%3A%2F%2Ffundingrequests.scwcsu.nhs.uk%2Fwp-content%2Fuploads%2F2021%2F12%2FTVPC32-Ultrasound-Guided-Injections-for-Hip-Pain-Policy-Update-v2-1.pdf]

Lincolnshire Hip uses ultrasound routinely as part of its image-guided hip injection pathway, aiming for consistent placement in the intended peri-trochanteric tissue plane and additional diagnostic clarity when hip joint and outer-hip symptoms overlap.

When the hip joint itself becomes the injection target

A switch in injection target is usually considered when lateral hip pain keeps behaving like “more than one problem” despite a well-executed trochanteric bursa approach. In GTPS the tender spot is often clearly over the greater trochanter, but some cohorts show a meaningful rate of concomitant intra‑articular hip pathology (for example labral or chondral lesions) that can continue to drive symptoms even after peri‑trochanteric treatment. [trafilatura:https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC4765286%2F; ai4scholar:1155dbee943450860dda42b176c012cca5af5327]

In practice, the “minority” group tends to declare itself through a pattern rather than a single symptom. Situations that commonly move the focus from the outer hip to the hip joint include:

• Failure of prior peri‑trochanteric care, including physiotherapy/NSAIDs and at least one peri‑trochanteric steroid injection, with persisting functional limitation. (This is the population studied in 2014.) [trafilatura:https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC4765286%2F]
• Mixed response to targeted injections: partial relief after a trochanteric injection but ongoing “deep hip” pain prompting a separate diagnostic question about the joint. [ai4scholar:1155dbee943450860dda42b176c012cca5af5327]
• Coexisting hip osteoarthritis or another joint diagnosis where an intra‑articular plan already forms part of the wider hip pathway. [msk_kb:6a73e13e-6a94-4301-9c4d-44f76932a382]

Evidence for the joint-target approach is limited but clinically important. A 2014 series (16 patients) with recalcitrant lateral hip pain reported significant improvement in modified Harris Hip Score at 1 week and 12 weeks after an ultrasound-guided intra‑articular hip corticosteroid injection, combined with physiotherapy and NSAIDs—supporting the idea that “occult” joint pathology was a key pain driver in that subset. [trafilatura:https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC4765286%2F]

Within a hip-only service such as Lincolnshire Hip, the decision is often framed as diagnosis versus symptom control. An editorial commentary recommends separate ultrasound-guided diagnostic injections into the peritrochanteric region and the hip joint (typically on different occasions) to localise the dominant pain generator; ultrasound is also noted to improve the accuracy of intra‑articular hip injections. [ai4scholar:1155dbee943450860dda42b176c012cca5af5327; trafilatura:https%3A%2F%2Fwww.aafp.org%2Fafp%2F2024%2F0100%2Fhip-and-knee-injections]

Even when the hip joint is the target, the injectate is individualised—commonly corticosteroid for an inflammatory flare, with other intra‑articular options (for example hyaluronic acid in hip osteoarthritis) considered in selected pathways. Routine GTPS injections at Lincolnshire Hip remain aimed at the trochanteric bursa region, with hip joint injections reserved for clearly defined mixed-pathology or diagnostic scenarios. Lincolnshire Hip is part of the MSK Doctors group and accepts patients without referral for hip assessment in Grantham and Sleaford. [echo_linker:494; echo_linker:496]

Deciding if a trochanteric bursa injection at Lincolnshire Hip is right for you

Putting the pattern of symptoms and the response to early treatment alongside the evidence tends to clarify whether a trochanteric bursa steroid injection is a sensible next step. In NHS patient information, greater trochanteric pain syndrome (GTPS) is often described as taking 6–12 months to settle, with flare-ups during progressive loading being common—so an injection is usually considered a way to reduce pain enough to keep rehabilitation moving, rather than a “finish line” in itself. [trafilatura:https%3A%2F%2Fwww.nhsinform.scot%2Fillnesses-and-conditions%2Fmuscle-bone-and-joints%2Fleg-and-foot-problems-and-conditions%2Fgreater-trochanteric-pain-syndrome%2F; trafilatura:https%3A%2F%2Fleedscommunityhealthcare.nhs.uk%2Four-services-a-z%2Fmusculoskeletal-msk%2Fhip-problems%2Fknown-diagnosed-hip-problems%2Fgreater-trochanteric-pain-syndrome-gtps-and-lateral-hip-pain%2F]

To make the end of the pathway explicit, the closing decision framework is:

• “Yes, it’s a good fit” features: persistent, localised outer-hip tenderness consistent with GTPS; symptoms limiting basics such as sleeping on the affected side, walking, or stairs; and limited improvement after a period of education, load modification and hip-focused strengthening (the core approach described in UK community MSK resources). [trafilatura:https%3A%2F%2Fwww.nhsinform.scot%2Fillnesses-and-conditions%2Fmuscle-bone-and-joints%2Fleg-and-foot-problems-and-conditions%2Fgreater-trochanteric-pain-syndrome%2F; trafilatura:https%3A%2F%2Fleedscommunityhealthcare.nhs.uk%2Four-services-a-z%2Fmusculoskeletal-msk%2Fhip-problems%2Fknown-diagnosed-hip-problems%2Fgreater-trochanteric-pain-syndrome-gtps-and-lateral-hip-pain%2F]
• “Pause and re-check the diagnosis” features: a picture dominated by groin pain or a “deep hip” joint-type pain pattern, or persistent functional limitation despite well-directed outer-hip care, where another hip pain generator may be contributing. [trafilatura:https%3A%2F%2Fleedscommunityhealthcare.nhs.uk%2Four-services-a-z%2Fmusculoskeletal-msk%2Fhip-problems%2Fknown-diagnosed-hip-problems%2Fgreater-trochanteric-pain-syndrome-gtps-and-lateral-hip-pain%2F]

Alongside any injection, the long-term “engine” remains rehabilitation. A 2025 network meta-analysis (19 RCTs, 1,701 participants) found structured exercise delivered the greatest overall improvements in pain and function over time, with injections tending to play more of an adjunct role. [ai4scholar:d094c277fd19ad2135c44c3a16c74bb469879c26]

A personalised plan in a hip-only pathway such as Lincolnshire Hip commonly combines the injection with a progressive programme for hip abductor strength, plus gait/posture coaching and a review of contributing loads (for example, work demands or footwear) and response over follow-up, adjusting the plan if progress stalls over weeks to months. [trafilatura:https%3A%2F%2Fleedscommunityhealthcare.nhs.uk%2Four-services-a-z%2Fmusculoskeletal-msk%2Fhip-problems%2Fknown-diagnosed-hip-problems%2Fgreater-trochanteric-pain-syndrome-gtps-and-lateral-hip-pain%2F]

Practical preparation points for a first appointment often include:

• a brief timeline of symptoms (for example, when night pain started and current walking tolerance)
• treatments already tried (physio focus, exercise adherence, analgesia, any prior injections)
• relevant medical factors that may affect injection planning (for example diabetes or blood thinners)
• 2–3 goals framed in everyday activities (stairs, getting in/out of a car, sleep).

Lincolnshire Hip is part of the MSK Doctors group and accepts patients without referral for hip assessment in Grantham and Sleaford. [echo_linker:494; echo_linker:496]

1. [1] Treatment of Concomitant Intra-Articular Pathology in Patients With Greater Trochanteric Pain Syndrome: Editorial Commentary. (2023). https://doi.org/10.1016/j.arthro.2022.08.014 https://doi.org/10.1016/j.arthro.2022.08.014
2. [2] Corticosteroid injection for greater trochanteric pain syndrome: a systematic review. (2021). https://doi.org/10.21037/MAP-21-AB084 https://doi.org/10.21037/MAP-21-AB084
3. [3] Effect of conservative treatment on greater trochanteric pain syndrome: a systematic review and network meta-analysis of randomized controlled trials. (2025). https://doi.org/10.1186/s13018-025-05477-w https://doi.org/10.1186/s13018-025-05477-w